Anti-Infectives for Systemic Use icon
Portfolio · Therapeutic Category J

Anti-Infectives for Systemic Use

"Effective today, and still effective in ten years."

Anti-infective dispensing setting, calm light
Antimicrobial supply is a stewardship question before it is a commercial one.
This category carries the portfolio’s widest span, from first-line oral antibiotics to reserve hospital injectables. VAIS™ weighs resistance-profile data and national treatment guidelines alongside manufacturing quality, because a molecule that undermines local stewardship policy is the wrong molecule however it prices.
Category Focus

Cold-chain and reserve-antibiotic candidates are screened against the destination market’s stewardship policy before VAIS™ will shortlist them.

Products in This Category
Filter by Product Type
Development Stage Sourcing Dossier Review Dossier Screening Product Submission Approval Launch
15 product(s) found
Product Indication Product Type Dosage Form Development Stage Product Information
Amoxicillin500 mg / 250 mg per 5 mL Bacterial infections Generic Capsule / Oral suspension
Dossier Review
Co-amoxiclav625 mg; 1 g / 1.2 g Bacterial infections Generic Tablet / Injection
Dossier Screening
Ceftriaxone1 g Serious bacterial infections Generic Injection
Product Submission
Meropenem500 mg; 1 g Severe hospital infections Generic Injection
Dossier Review
Vancomycin500 mg; 1 g MRSA infections Generic Injection
Dossier Screening
Gentamicin80 mg/2 mL Gram-negative infections Generic Injection
Dossier Review
Azithromycin250 mg; 500 mg Respiratory tract infections Generic Tablet
Dossier Screening
Levofloxacin500 mg Respiratory & urinary infections Generic Tablet
Dossier Screening
Moxifloxacin400 mg / 400 mg per 250 mL Community-acquired pneumonia Generic Tablet / Infusion
Dossier Review
Metronidazole400 mg / 500 mg per 100 mL Anaerobic & protozoal infections Generic Tablet / Infusion
Dossier Screening
Rifampicin150 mg; 300 mg Tuberculosis Generic Capsule
Sourcing
Voriconazole200 mg Invasive aspergillosis Generic Tablet / Injection
Sourcing
Entecavir0.5 mg Chronic hepatitis B Generic Tablet
Dossier Screening
Oseltamivir75 mg Influenza A and B Generic Capsule
Product Submission
BCG VaccineSingle-dose / multi-dose vial Tuberculosis immunisation Innovative Injection (lyophilised)
Sourcing
Request the Evaluation Summary